The Epidemiology of Diabetes Interventions and Complications study revealed that the incidence of obesity in T1D patients has significantly increased due to widespread intense insulin treatment following Diabetes Control and Complications Trial (23,24,25). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.